Orexigen® Therapeutics' Investigational Drug Contrave® Receives Positive Recommendation from FDA Advisory Committee for Treatment of Obesity
Montreux Equity Partners named once again to the "AlwaysOn Top VC 100"
GC Aesthetics Secures $30 Million in Financing from Montreux Equity Partners
Watson, Moksha8 Form Marketing Partnership for Brazil, Mexico; Watson Makes Initial $30 Million Investment
Boston Scientific to Acquire Asthmatx
Orexigen(R) Therapeutics and Takeda Enter Into Partnership to Commercialize Contrave(R) in North America
Asthmatx files with U.S. SEC for $75 million IPO
Johnson & Johnson Announces Agreement to Acquire Peninsula Pharmaceuticals, Inc.
Peninsula Pharmaceuticals Names Dennis Podlesak Chief Executive Officer and President
Avera Pharmaceuticals Raises $48 Million in Series C Venture Financing